Effects of serum factors in patents with ME/CFS after COVID-19 on endothelial cell function in vitro

In her poster presentation, Kanchan Dulal presented findings from her study on the pathomechanisms of impaired vascular function in PCS and ME/CFS post COVID-19, with the aim to identify biomarkers for endothelial dysfunction in both conditions. Analyses of endothelial cells treated with serum from patients revealed an increased release of molecules capable of inhibiting NO synthesis, thereby providing indirect evidence for dysregulated vascular function and subsequently possible endothelial dysfunction in PCS and ME/CFS.